2022
DOI: 10.3390/ijms23041996
|View full text |Cite
|
Sign up to set email alerts
|

Remodeling of Lipid A in Pseudomonas syringae pv. phaseolicola In Vitro

Abstract: Pseudomonas species infect a variety of organisms, including mammals and plants. Mammalian pathogens of the Pseudomonas family modify their lipid A during host entry to evade immune responses and to create an effective barrier against different environments, for example by removal of primary acyl chains, addition of phosphoethanolamine (P-EtN) to primary phosphates, and hydroxylation of secondary acyl chains. For Pseudomonas syringae pv. phaseolicola (Pph) 1448A, an economically important pathogen of beans, we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2

Relationship

4
4

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 73 publications
0
3
0
Order By: Relevance
“…Additionally, different bacteria use mc-3-OH-FAs as building blocks in various other compounds, such as lipopeptides (Souza et al ., 2003; Raaijmakers et al ., 2006), HAAs and rhamnolipids (Abdel-Mawgoud et al ., 2010), N-acyl-homoserine lactone-type quorum sensing molecules (Williams, 2007; Thiel et al ., 2009), or polyhydroxyalkanoates (Raza et al ., 2018; Paduvari et al ., 2024). While most of these compounds do not activate LORE-mediated immunity directly (Kutschera et al ., 2019), mc-3-OH-FAs could be released from these compounds or the ACP/CoA-bound precursors (Zheng, Z. et al ., 2004; Zheng, Zhong et al ., 2004; Geurtsen et al ., 2005; Ernst et al ., 2006; Kutschera et al ., 2019; Gerster et al ., 2022). Free 3-OH-C10:0 FAs are, for example, prevalent in the secretome of Pseudomonas spp.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, different bacteria use mc-3-OH-FAs as building blocks in various other compounds, such as lipopeptides (Souza et al ., 2003; Raaijmakers et al ., 2006), HAAs and rhamnolipids (Abdel-Mawgoud et al ., 2010), N-acyl-homoserine lactone-type quorum sensing molecules (Williams, 2007; Thiel et al ., 2009), or polyhydroxyalkanoates (Raza et al ., 2018; Paduvari et al ., 2024). While most of these compounds do not activate LORE-mediated immunity directly (Kutschera et al ., 2019), mc-3-OH-FAs could be released from these compounds or the ACP/CoA-bound precursors (Zheng, Z. et al ., 2004; Zheng, Zhong et al ., 2004; Geurtsen et al ., 2005; Ernst et al ., 2006; Kutschera et al ., 2019; Gerster et al ., 2022). Free 3-OH-C10:0 FAs are, for example, prevalent in the secretome of Pseudomonas spp.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast to some other cystic fibrosis isolates, RP73 does not contain LPS mutations that typically confer increased resistance to AMPs, such as the addition of aminoarabinose to the free phosphate groups of the glucosamine backbone ( 62 , 63 ). However, the under-acylation of LPS molecules has in the past also been linked to increased AMP and polymyxin resistance in various Gram-negative bacteria ( 64 67 ). For P. aeruginosa specifically, strains with penta-acylated LPS structures are less susceptible to polymyxin B due to decreased hydrophobic interactions ( 67 ).…”
Section: Discussionmentioning
confidence: 99%
“…Details on the lipid A molecular species can be found in Table S2. MS 2 experiments for further detailed analysis of the lipid A structure were performed as described previously ( 61 ). All samples of the NBD-glycerol-PEA TLC-based assay were diluted 20-fold in the spray solution comprising water–propan-2-ol–7 M triethylamine–acetic acid (50:50:0.06:0.02 [vol/vol/vol/vol]) and then centrifuged briefly at 16,000 × g at room temperature.…”
Section: Methodsmentioning
confidence: 99%